Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain
- PMID: 21524850
- DOI: 10.1016/j.pain.2011.03.023
Comparative mortality among Department of Veterans Affairs patients prescribed methadone or long-acting morphine for chronic pain
Abstract
Data on comparative safety of opioid analgesics are limited, but some reports suggest disproportionate mortality risk associated with methadone. Our objective was to compare mortality rates among patients who received prescribed methadone or long-acting morphine for pain. This is a retrospective observational cohort drawn from Department of Veterans Affairs (VA) health care databases, January 1, 2000, to December 31, 2007. We included 28,554 patients who received methadone and 79,938 who received long-acting morphine from VA pharmacies. Compared with those who received long-acting morphine, patients who received methadone were younger, less likely to have some medical comorbidities, and more likely to have psychiatric and substance use disorders. Patients were stratified into quintiles according to propensity score; the probability of receiving methadone was conditional on demographic, clinical, and VA service area variables. Overall propensity-adjusted mortality was lower for methadone than for morphine. Hazard ratios varied across propensity score quintiles; the magnitude of the between-drug difference in mortality decreased as the propensity to receive methadone increased. Mortality was significantly lower for methadone in all but the last quintile, in which there was no between-drug difference in mortality (hazard ratio=0.92, 95% confidence interval=0.74, 1.16). Multiple sensitivity analyses found either no difference in mortality between methadone and long-acting morphine or lower mortality rates among patients who received methadone. In summary, we found no evidence of excess all-cause mortality among VA patients who received methadone compared with those who received long-acting morphine. Randomized trials and prospective observational research are needed to better understand the relative safety of long-acting opioids.
Published by Elsevier B.V.
Similar articles
-
Opioid dispensing and overlap in veterans with non-cancer pain eligible for Medicare Part D.J Am Pharm Assoc (2003). 2017 May-Jun;57(3):333-340.e3. doi: 10.1016/j.japh.2017.02.018. Epub 2017 Apr 10. J Am Pharm Assoc (2003). 2017. PMID: 28408172
-
Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain.JAMA. 2016 Jun 14;315(22):2415-23. doi: 10.1001/jama.2016.7789. JAMA. 2016. PMID: 27299617 Free PMC article.
-
Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain.Pain Med. 2011 Oct;12(10):1502-9. doi: 10.1111/j.1526-4637.2011.01226.x. Epub 2011 Sep 7. Pain Med. 2011. PMID: 21899715 Free PMC article.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Morphine to methadone conversion: an interpretation of published data.Am J Hosp Palliat Care. 2011 Mar;28(2):135-40. doi: 10.1177/1049909110373508. Epub 2010 Jun 16. Am J Hosp Palliat Care. 2011. PMID: 20555039 Review.
Cited by
-
Unveiling Morphine: A Rapid and Selective Fluorescence Sensor for Forensic and Medical Analysis.Sensors (Basel). 2024 Mar 7;24(6):1722. doi: 10.3390/s24061722. Sensors (Basel). 2024. PMID: 38543983 Free PMC article.
-
Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review.Drug Des Devel Ther. 2022 Jan 18;16:251-264. doi: 10.2147/DDDT.S342409. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35082488 Free PMC article. Review.
-
A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease.Sci Rep. 2021 Mar 25;11(1):6874. doi: 10.1038/s41598-021-86326-8. Sci Rep. 2021. PMID: 33767311 Free PMC article. Clinical Trial.
-
Against Repurposing Methadone for Glioblastoma Therapy.Biomolecules. 2020 Jun 17;10(6):917. doi: 10.3390/biom10060917. Biomolecules. 2020. PMID: 32560384 Free PMC article. Review.
-
Comprehensive Perioperative Management Considerations in Patients Taking Methadone.Curr Pain Headache Rep. 2019 Jun 17;23(7):49. doi: 10.1007/s11916-019-0783-z. Curr Pain Headache Rep. 2019. PMID: 31209656 Review.
References
-
- Increase in Poisoning Deaths Caused by Non-Illicit Drugs—Utah, 1991–2003. JAMA 2005;293:1182–83.
-
- American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331–46.
-
- Chou R, Ballantyne JC, Fanciullo GJ, Fine PG, Miaskowski C. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:147-159.
-
- Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008;121:66-71.
-
- Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Can Med Assoc J. 2009;181:891-896.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical